F.-P.Chen placental villi and trophoblasts (Szulman and Surti, 1978a,b) . Therefore, hydatidiform mole with a coexisting fetus can be established by the partial mole syndrome or by a twin pregnancy where the other conceptus has degenerated into a mole. In our present case, the fetal karyotype 46,XY and the histopathological and morphological findings of a normal placenta and separated molar tissues with marked hydrophic avascular villi support the theoretical explanation that it resulted from a twin dizygotic pregnancy in which one twin had developed normally and the other had degenerated into a complete mole.
Prenatal diagnosis of coexistent mole and fetus can depend upon the clinical symptoms and signs, physical examination, sonographic findings, and abnormal biochemical data. Clinically, the patient may present hyperemesis, hyperthyroidism, vaginal spotting or even heavy bleeding, pregnancy-induced hypertension and larger-than-gestational age uterus. However, these conditions are not always present, as none of these symptoms and signs were seen in the present case. Ultrasound examination usually provides a reliable means for the diagnosis of molar pregnancy. The typical ultrasonographic findings of a molar pregnancy consist of a complex cystic pattern with a 'snowstorm' appearance, but it should be differentiated from a during the early pregnancy, or even a partially necrotic leioplacenta was noted by ultrasound. M ϭ hydatidiform mole; P ϭ myoma which can produce a similar appearance (Sauerbree placenta. et al., 1980) . The difference between a partial and a complete mole cannot be firmly established by ultrasound because they 'cistern' formation and vessels were absent, which is compatboth present with the same vesicular pattern. However, in our ible with the complete hydatidiform mole.
case, the ultrasound clearly revealed not only a normal During the postpartum period, the patient had an uneventful appearing fetus, but also a normal placenta connecting with course and received regular follow-up of β-HCG and the baby the sharply defined molar tissues. Since the normal placenta was well developed at time of reporting. Serum β-HCG titre separate from molar tissues can be well defined, a complete had the normal regression curve during the first month after mole pregnancy with a concurrent fetus can be diagnosed the birth. However, during the following month a rising prenatally. It is important to distinguish between a complete tendency was noted ( Figure 3) . A chest X-ray and Doppler and partial mole when a fetus coexists, because it has been ultrasound examination of the uterus did not reveal any reported that a complete mole has a 20% tendency to become abnormality. Therefore, the patient received four courses of an invasive mole or even a choriocarcinoma, while the risk methotrexate (1 mg/kg every other day combined with folinic was far less for partial moles (Callen, 1988) . The β-HCG titre acid every other day for 1 week each course). Serum β-HCG is generally higher than is seen in non-molar gestations. titre fell promptly after the first methotrexate course, but then Free β-HCG is often used for prenatal screening of Down's fell slowly and plateaued in the following three methotrexate syndrome. Khazaeli et al. (1989) suggested that the excessive courses (Figure 3 ). At this time, chest and abdominal computer production of free β-HCG may identify gestational trophotomography and Doppler ultrasound examination of uterus still blastic disease in patients during pregnancy and also identifies showed no significant findings. Therefore, the chemotherapy patients with a high risk of gestational trophoblastic disease. was changed to actinomycin D treatment (0.45 mg/kg for 5 However, a relationship between free β-HCG and coexisting days every course) for three courses, after which serum β-molar pregnancy has not been reported. In the present case, HCG fell to a normal level and has remained so at the the patient had an extremely high of concentration of free β-time of writing. At present, the patient is well, using oral HCG which not only confirmed the sonographic diagnosis of contraceptives and still has regular follow-up of β-HCG.
combined molar pregnancy, but also presented the possibility of later developing gestational trophoblastic disease, in addition Discussion to the risk from the complete mole and term pregnancy. Therefore, the use of ultrasound, augmented by the significantly Hydatidiform mole can be separated into two entities with respect to cytogenetics, histopathology and morphology: firstly, elevated β-HCG value, especially free β-HCG, and clinical symptoms and signs, has facilitated the accurate prenatal complete, classical mole has diploid karyotype, no embryo and amnion, and uniform changes of the placental villi and diagnosis of coexistent mole and fetus. Molar pregnancy with a coexisting fetus progressing to a trophoblasts; secondly, partial mole usually has a triploid karyotype, the presence of ascertainable embryo, umbilical viable, healthy infant is an extreme rarity. In most of these cases, the pregnancy is terminated due to severe complications cord or an amniotic membrane, and only focal changes of 854 prgmea.com outcome and the possible complications of such a pregnancy. Vejerslev (1991) reviewed 113 reports of pregnancies with mole and fetus in which there appeared to be no major malformations or cytogenetic abnormalities. Of these, 87 had intended to continue the pregnancy with or without knowledge of accompanying mole; in fact, 52 pregnancies (59.8%) proceeded to the 28th week, and a risk for either substantial bleeding or pre-eclamptic symptoms developed in~30%. Iñ 15% the degree of severity required termination on clinical grounds irrespective of fetal development. Before week 28 there is essentially no hope for a surviving child and the chance for continuation of the pregnancy beyond this point is 60%. Of pregnancies which continue beyond the 28th week, a surviving child may be expected in~70% of pregnancies, the risk for intrauterine or neonatal death being~30%. On the other hand, persistent trophoblastic disease was reported in 19.2% of pregnancies interrupted at diagnosis, as well as in 9.1% of those who had continued (Vejerslev, 1991) . In addition, no reports demonstrate that if pregnancy is kept to term, it such as vaginal bleeding, pre-eclampsia and missed abortion.
will increase the incidence of invasive mole or choriocarcinSome recommend immediate termination even in the absence oma. Nwosu et al. (1995) even demonstrated a case in which of any complication (Jones and Lauersen, 1975; Garcia-Aguayo there was no sign of recurrence or trophoblastic disease and Irles, 1988). As a result, management of molar pregnancy developing in a patient after delivery of coexisting molar with coexisting fetus remains controversial. In the present pregnancy and a living normal baby at term. Some reports case, the decision of the patient to continue the pregnancy was showed that chemotherapy or hysterectomy were required accepted, not only because of normal karyotype, appearance later, even when termination of the pregnancy during early and good fetal development, but also because no significant gestation was required treatment in the condition (Fisher et al., symptoms and signs presented. Although we demonstrate that 1982; Teng and Ballon, 1984; Garcia-Aguayo and Irles, 1988 ). a complete molar pregnancy with a normal concurrent fetus In our case, the postpartum chemotherapy was fairly noncan permit the normal development of the fetus until term aggressive. It may be better to initiate more aggressive with a good fetal and maternal outcome, we cannot ignore the prophylactic chemotherapy immediately after termination of high risk of developing persistent gestational trophoblastic coexisting complete and molar pregnancy. disease later, especially with the presence of a significantly
In conclusion, for molar pregnancy with a coexisting fetus, in high concentration of free β-HCG and complete mole. Thereaddition to the chromosomal evaluation and detailed ultrasound examination to exclude fetal abnormality before the decision fore, proper prenatal consultation should consider both the F.-P.Chen to postpone intervention, prenatal consultation should include complete discussion of maternal and fetal risks, especially the possible requirement of chemotherapy or even hysterectomy. It is also necessary to have close follow-up and evaluation of the condition of the patient during the prenatal and postnatal period.
